Andreas Gollner

1.5k total citations
23 papers, 478 citations indexed

About

Andreas Gollner is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Andreas Gollner has authored 23 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Andreas Gollner's work include Cancer-related Molecular Pathways (7 papers), Synthetic Organic Chemistry Methods (4 papers) and Catalytic C–H Functionalization Methods (3 papers). Andreas Gollner is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Synthetic Organic Chemistry Methods (4 papers) and Catalytic C–H Functionalization Methods (3 papers). Andreas Gollner collaborates with scholars based in Austria, Germany and United States. Andreas Gollner's co-authors include Scott A. Snyder, Johann Mulzer, Panayiotis A. Koutentis, Jürg Gertsch, Karl‐Heinz Altmann, Konrad Tiefenbacher, H. A. Ioannidou, Aaron Martin, Darryl B. McConnell and Dorothea Rudolph and has published in prestigious journals such as Nature, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Andreas Gollner

23 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Gollner Austria 11 287 182 79 70 60 23 478
Dominic J. Reynolds United Kingdom 15 409 1.4× 327 1.8× 54 0.7× 62 0.9× 19 0.3× 29 637
Jung‐Nyoung Heo South Korea 18 653 2.3× 256 1.4× 24 0.3× 62 0.9× 61 1.0× 41 874
Fiona Hogan United States 6 380 1.3× 298 1.6× 84 1.1× 157 2.2× 108 1.8× 9 637
Christopher M. Adams United States 13 422 1.5× 200 1.1× 82 1.0× 80 1.1× 19 0.3× 25 590
Ravi Naik South Korea 11 190 0.7× 264 1.5× 13 0.2× 60 0.9× 54 0.9× 20 529
Dashan Li China 13 310 1.1× 147 0.8× 32 0.4× 89 1.3× 64 1.1× 53 582
Zhanzhu Liu China 13 245 0.9× 119 0.7× 82 1.0× 120 1.7× 27 0.5× 41 440
Jianghe Deng United States 9 352 1.2× 173 1.0× 29 0.4× 20 0.3× 31 0.5× 12 507
Jianlei Wu China 10 204 0.7× 172 0.9× 40 0.5× 125 1.8× 39 0.7× 26 464
Kshitij Thakkar United States 10 188 0.7× 143 0.8× 9 0.1× 76 1.1× 33 0.6× 11 458

Countries citing papers authored by Andreas Gollner

Since Specialization
Citations

This map shows the geographic impact of Andreas Gollner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Gollner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Gollner more than expected).

Fields of papers citing papers by Andreas Gollner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Gollner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Gollner. The network helps show where Andreas Gollner may publish in the future.

Co-authorship network of co-authors of Andreas Gollner

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Gollner. A scholar is included among the top collaborators of Andreas Gollner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Gollner. Andreas Gollner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Covini, David, et al.. (2024). Synthesis of Indazoles via N–N Bond-Forming Oxidative Cyclization from 2-Aminomethyl-phenylamines. Organic Letters. 26(6). 1229–1232. 2 indexed citations
2.
Gollner, Andreas, et al.. (2023). Kinase Degraders, Activators, and Inhibitors: Highlights and Synthesis Routes to the Chemical Probes on opnMe.com, Part 1. ChemMedChem. 18(10). e202300031–e202300031. 1 indexed citations
3.
Martinelli, Paola, Otmar Schaaf, Andreas Mantoulidis, et al.. (2023). Discovery of a Chemical Probe to Study Implications of BPTF Bromodomain Inhibition in Cellular and in vivo Experiments. ChemMedChem. 18(6). e202200686–e202200686. 3 indexed citations
4.
Keeble, Alexander R., Yuan Wen, Nicholas T. Thomas, et al.. (2023). Inhibition of p53-MDM2 binding reduces senescent cell abundance and improves the adaptive responses of skeletal muscle from aged mice. GeroScience. 46(2). 2153–2176. 10 indexed citations
6.
Ramharter, Jürgen, et al.. (2022). Synthesis of MDM2-p53 Inhibitor BI-0282 via a Dipolar Cycloaddition and Late-Stage Davis–Beirut Reaction. Organic Process Research & Development. 26(8). 2526–2531. 2 indexed citations
7.
Bergner, Andreas, Xiaoling Cockcroft, Gerhard W. Fischer, et al.. (2019). KRAS Binders Hidden in Nature. Chemistry - A European Journal. 25(52). 12037–12041. 16 indexed citations
8.
Rudolph, Dorothea, Andreas Gollner, Sophia M. Blake, et al.. (2018). Abstract 4868: BI 907828: A novel, potent MDM2 inhibitor that is suitable for high-dose intermittent schedules. Cancer Research. 78(13_Supplement). 4868–4868. 4 indexed citations
9.
Gollner, Andreas, Harald Weinstabl, Julian E. Fuchs, et al.. (2018). Targeted Synthesis of Complex Spiro[3H‐indole‐3,2′‐pyrrolidin]‐2(1H)‐ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2–p53 Inhibitors. ChemMedChem. 14(1). 88–93. 21 indexed citations
10.
Rinnenthal, Joerg, Dorothea Rudolph, Sophia M. Blake, et al.. (2018). Abstract 4865: BI 907828: A highly potent MDM2 inhibitor with low human dose estimation, designed for high-dose intermittent schedules in the clinic. Cancer Research. 78(13_Supplement). 4865–4865. 12 indexed citations
11.
Rudolph, Dorothea, Markus Reschke, Sophia M. Blake, et al.. (2018). Abstract 4866: BI 907828: A novel, potent MDM2 inhibitor that induces antitumor immunologic memory and acts synergistically with an anti-PD-1 antibody in syngeneic mouse models of cancer. Cancer Research. 78(13_Supplement). 4866–4866. 9 indexed citations
12.
13.
Snyder, Scott A., et al.. (2011). Regioselective reactions for programmable resveratrol oligomer synthesis. Nature. 474(7352). 461–466. 176 indexed citations
14.
Ioannidou, H. A., Aaron Martin, Andreas Gollner, & Panayiotis A. Koutentis. (2011). Three-Step Synthesis of Ethyl Canthinone-3-carboxylates from Ethyl 4-Bromo-6-methoxy-1,5-naphthyridine-3-carboxylate via a Pd-Catalyzed Suzuki–Miyaura Coupling and a Cu-Catalyzed Amidation Reaction. The Journal of Organic Chemistry. 76(12). 5113–5122. 24 indexed citations
16.
Tiefenbacher, Konrad, Andreas Gollner, & Johann Mulzer. (2010). Syntheses and Antibacterial Properties of iso‐Platencin, Cl‐iso‐Platencin and Cl‐Platencin: Identification of a New Lead Structure. Chemistry - A European Journal. 16(31). 9616–9622. 28 indexed citations
17.
Gollner, Andreas & Panayiotis A. Koutentis. (2010). Two-Step Total Syntheses of Canthin-6-one Alkaloids: New One-Pot Sequential Pd-Catalyzed Suzuki−Miyaura Coupling and Cu-Catalyzed Amidation Reaction. Organic Letters. 12(6). 1352–1355. 33 indexed citations
18.
Gollner, Andreas, Karl‐Heinz Altmann, Jürg Gertsch, & Johann Mulzer. (2009). The Laulimalide Family: Total Synthesis and Biological Evaluation of Neolaulimalide, Isolaulimalide, Laulimalide and a Nonnatural Analogue. Chemistry - A European Journal. 15(24). 5979–5997. 47 indexed citations
19.
Gollner, Andreas, Karl‐Heinz Altmann, Jürg Gertsch, & Johann Mulzer. (2009). Synthesis and biological evaluation of a des-dihydropyran laulimalide analog. Tetrahedron Letters. 50(42). 5790–5792. 16 indexed citations
20.
Gollner, Andreas & Johann Mulzer. (2008). Total Synthesis of Neolaulimalide and Isolaulimalide. Organic Letters. 10(20). 4701–4704. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026